- Home
- PFO vs RPTX Comparison
PFO vs RPTX Comparison
Compare PFO & RPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PFO
- RPTX
- Stock Information
- Founded
- PFO 1991
- RPTX 2016
- Country
- PFO United States
- RPTX Canada
- Employees
- PFO N/A
- RPTX N/A
- Industry
- PFO Finance Companies
- RPTX Biotechnology: Pharmaceutical Preparations
- Sector
- PFO Finance
- RPTX Health Care
- Exchange
- PFO Nasdaq
- RPTX Nasdaq
- Market Cap
- PFO 121.4M
- RPTX 69.2M
- IPO Year
- PFO N/A
- RPTX 2020
- Fundamental
- Price
- PFO $9.73
- RPTX $1.74
- Analyst Decision
- PFO
- RPTX Strong Buy
- Analyst Count
- PFO 0
- RPTX 3
- Target Price
- PFO N/A
- RPTX $4.50
- AVG Volume (30 Days)
- PFO 31.8K
- RPTX 97.5K
- Earning Date
- PFO 01-01-0001
- RPTX 11-06-2025
- Dividend Yield
- PFO 6.51%
- RPTX N/A
- EPS Growth
- PFO N/A
- RPTX N/A
- EPS
- PFO N/A
- RPTX N/A
- Revenue
- PFO N/A
- RPTX $250,000.00
- Revenue This Year
- PFO N/A
- RPTX N/A
- Revenue Next Year
- PFO N/A
- RPTX N/A
- P/E Ratio
- PFO N/A
- RPTX N/A
- Revenue Growth
- PFO N/A
- RPTX N/A
- 52 Week Low
- PFO $6.90
- RPTX $0.89
- 52 Week High
- PFO $8.51
- RPTX $4.07
- Technical
- Relative Strength Index (RSI)
- PFO 85.98
- RPTX 62.38
- Support Level
- PFO $9.40
- RPTX $1.66
- Resistance Level
- PFO $9.31
- RPTX $1.82
- Average True Range (ATR)
- PFO 0.06
- RPTX 0.06
- MACD
- PFO 0.03
- RPTX 0.00
- Stochastic Oscillator
- PFO 100.00
- RPTX 64.00
About PFO Flaherty & Crumrine Preferred and Income Opportunity Fund Incorporated
Flaherty & Crumrine Prfd Income Oppo is the United States-based diversified, closed-end management investment company. Its primary investment objective is to provide its common shareholders with high current income consistent with the preservation of capital. The fund invests in a diversified portfolio of preferred securities which includes traditional preferred stocks eligible for the inter-corporate dividends received a deduction and fully taxable preferred securities.
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.